InspireMD (NSPR)
(Delayed Data from NSDQ)
$2.91 USD
-0.05 (-1.69%)
Updated Aug 16, 2024 04:00 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Income Statements
Fiscal Year end for InspireMD, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6 | 5 | 5 | 2 | 4 |
Cost Of Goods | 4 | 4 | 4 | 2 | 3 |
Gross Profit | 2 | 1 | 1 | 0 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 23 | 20 | 15 | 10 | 11 |
Income After Depreciation & Amortization | -21 | -19 | -15 | -10 | -10 |
Non-Operating Income | 1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -20 | -18 | -15 | -11 | -10 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -20 | -18 | -15 | -11 | -10 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -20 | -18 | -15 | -11 | -10 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -21 | -19 | -15 | -10 | -10 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -21 | -19 | -15 | -10 | -10 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 24.27 | 7.87 | 7.35 | 1.51 | 0.14 |
Diluted EPS Before Non-Recurring Items | -0.82 | -2.35 | -2.03 | -6.90 | -71.96 |
Diluted Net EPS (GAAP) | -0.82 | -2.35 | -2.03 | -6.90 | -71.96 |
Fiscal Year end for InspireMD, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1.74 | 1.51 | 1.76 | 1.56 | 1.65 |
Cost Of Goods | 1.41 | 1.22 | 1.26 | 1.12 | 1.16 |
Gross Profit | 0.33 | 0.29 | 0.51 | 0.44 | 0.49 |
SG&A, R&D, and Dept/Amort Expenses | 8.59 | 7.71 | 6.32 | 6.08 | 5.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | -8.26 | -7.42 | -5.81 | -5.64 | -5.31 |
Non-Operating Income | 0.35 | 0.38 | 0.47 | 0.46 | 0.24 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -7.91 | -7.03 | -5.34 | -5.18 | -5.08 |
Income Taxes | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.91 | -7.03 | -5.41 | -5.18 | -5.08 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -7.91 | -7.03 | -5.41 | -5.18 | -5.08 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 35.88 | 34.24 | 33.94 | 33.99 | 21.07 |
Diluted EPS Before Non-Recurring Items | -0.22 | -0.21 | -0.16 | -0.15 | -0.24 |
Diluted Net EPS (GAAP) | -0.22 | -0.21 | 0.10 | -0.15 | -0.24 |